|
Ronald H. Spair joined the Company November 2001 as Executive Vice President and Chief Financial Officer and was recently promoted to Chief Operating Officer in October of 2006.
Mr. Spair brings extensive senior financial experience in the pharmaceutical and biotechnology industries to OraSure Technologies. His most recent position was with Delsys Pharmaceutical Corporation as Vice President and Chief Financial Officer. Prior to Delsys he was Chief Financial Officer for three public companies Supergen Inc. Sparta Pharmaceuticals Inc. and Envirogen Inc. During this period Mr. Spair had responsibility for directing finance accounting financial planning treasury human resources risk management and information technology matters at these companies. Mr. Spair has also had extensive experience negotiating mergers and acquisitions development and licensing transactions and corporate financings.
Mr. Spair is a Certified Public Accountant and received both his BS in Accounting and his MBA from Rider College. | 